Impact of post-ASCT maintenance therapy on outcomes in patients with newly diagnosed multiple myeloma in Connect MM

Autologous stem cell transplantation (ASCT) followed by lenalidomide maintenance therapy is the standard of care for transplant-eligible patients with newly diagnosed multiple myeloma (NDMM). Clinical trials show progression-free survival (PFS) benefits, with some studies (Cancer and Leukemia Group...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Blood Adv
Κύριοι συγγραφείς: Jagannath, Sundar, Abonour, Rafat, Durie, Brian G. M., Narang, Mohit, Terebelo, Howard R., Gasparetto, Cristina J., Toomey, Kathleen, Hardin, James W., Wagner, Lynne, Agarwal, Amit, Srinivasan, Shankar, Kitali, Amani, Flick, E. Dawn, Sturniolo, Michael, Rifkin, Robert M.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: American Society of Hematology 2018
Θέματα:
Clinical Trials and Observations
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6039656/
https://ncbi.nlm.nih.gov/pubmed/29986853
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018017186
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια